lymphoma


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

lym·pho·ma

 (lĭm-fō′mə)
n. pl. lym·pho·ma·ta (-mə-tə) or lym·pho·mas
1. Any of various malignant tumors that arise from the lymphocytic cells of the immune system.
2. Any of various cancers characterized by the development of such tumors, especially Hodgkin lymphoma and non-Hodgkin lymphoma.

lym·pho′ma·toid′, lym·pho′ma·tous (-təs) adj.

lymphoma

(lɪmˈfəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) any form of cancer of the lymph nodes. Also called: lymphosarcoma
lymˈphomatous, lymˈphomaˌtoid adj

lym•pho•ma

(lɪmˈfoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor arising from any of the cellular elements of lymph nodes.
[1870–75]
lym•pho′ma•toid`, adj.

lymphoma

a growth of lymphoid tissue that is commonly cancerous and typically enlarges the lymph nodes.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
cancer, malignant neoplastic disease - any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream
Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
Translations
lymfom

lym·pho·ma

n. linfoma, neoplasma del tejido linfático.

lymphoma

n linfoma m; B cell — linfoma de células B; Hodgkin’s — linfoma (de) Hodgkin; mucosa-associated lymphoid tissue (MALT) — linfoma MALT, linfoma de tejido linfoide asociado a mucosas; non-Hodgkin’s — linfoma no Hodgkin; T cell — linfoma de células T
References in periodicals archive ?
In the pediatric population, the more frequent presentation of Burkitt lymphoma is that of a large painful and rapidly growing mass of the abdomen with ascites.
Every 28 minutes someone is diagnosed with lymphoma. It is the UK's fifth most common cancer, and the most common form of blood cancer, yet it is neither well known nor easily understood - and we want that to change.
M2 PRESSWIRE-August 14, 2019-: Mantle Cell Lymphoma Therapeutics Market: Comprehensive study explores Huge Growth in Future | Key Players- Allergan Plc, AstraZeneca Plc, Celgene
Celgene announced the FDA approved Revlimid in combination with a rituximab product for the treatment of adult patients with previously treated follicular lymphoma, or FL, or marginal zone lymphoma, or MZL, following Priority Review designation.
Our objective was to review clinical presentation, treatment protocol used and its efficacy and effectiveness in patients of grey zone lymphoma during last 5 years at our centre.
KEYWORDS: Anemia, Hodgkin lymphoma, Non Hodgkin lymphoma.
M2 PHARMA-February 11, 2019-Seattle Genetics Achieves USD 30m Milestone Payment for European Commission Approval of Adcetris in Frontline Hodgkin Lymphoma
By definition, primary cutaneous follicle center lymphoma (PCFCL) is a lymphoma of follicle center B cells without evidence of systemic/nodal involvement at the time of diagnosis.
M2 EQUITYBITES-October 4, 2018-Daiichi Sankyo Company wins Japanese orphan drug designation for Axicabtagene Ciloleucel for treating B-Cell Lymphoma
Global Banking News-October 4, 2018-Daiichi Sankyo Company wins Japanese orphan drug designation for Axicabtagene Ciloleucel for treating B-Cell Lymphoma
Both FeLV and FIV have been associated with the risk of lymphoma in cats.
ARE you or any of your family/friends affected by lymphoma or any other blood cancer?

Full browser ?